Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
04:23aSINOVAC BIOTECH : Thailand to cease Sinovac vaccine use when stocks end this month
RE
12:42aGENMAB A/S : Janssen Receive Positive Opinion for Lung Cancer Treatment from EU Committee
MT
12:23aCORRECTION : US FDA Panel Backs Second Dose of Johnson & Johnson's COVID-19 Jab
MT
12:11aJOHNSON & JOHNSON : US FDA Panel Backs Second Dose of Johson & Johnson's COVID-19 Jab
MT
10/17ROCHE : Heirs to Shut Down Philanthropic Foundation Focused on Nature Conservation
MT
10/17ROCHE : Wins US FDA Nod For Non-Small Cell Lung Cancer Therapy Tecentriq
MT
10/17MODERNA : U.S. administers 408.3 mln doses of COVID-19 vaccines - CDC
RE
10/17ROCHE : family shareholders will maintain stability - vice chairman
RE
10/16MODERNA : U.S. administers 407.4 mln doses of COVID-19 vaccines -CDC
RE
10/15S&P 500 Posts 1.8% Weekly Gain, Strongest Since July, Amid Positive Start to Q3 Results..
MT
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Receives FDA Advisory Panel Recommendati..
MT
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Wins FDA Advisory Panel's Backing as Booster for Adul..
MT
10/15MODERNA : COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different ..
RE
10/15JOHNSON & JOHNSON : Janssen Gets Positive Opinion on Lung Cancer Treatment From European M..
MT
10/15FDA PANEL BACKS JOHNSON & JOHNSON CO : Bloomberg
MT
10/15MODERNA : U.S. FDA delays decision on Moderna's COVID-19 vaccine for adolescents - WSJ
RE
10/15PRESS RELEASE : US FDA approves Roche's Tecentriq -2-
DJ
10/15PRESS RELEASE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people..
DJ
10/15MODERNA : U.S. FDA advisers to vote on J&J COVID-19 vaccine booster
RE
10/15GENENTECH : FDA Approves Tecentriq as Adjuvant Treatment for Certain Lung Cancer Patients
DJ
10/15PFIZER : BioNTech Makes European Medicines Agency Submission of Data Focusing COVID-19 Vac..
MT
10/15BIONTECH : Pfizer Seek European Medicines Agency's Approval for COVID-19 Vaccine for Young..
MT
10/15PRO BANKRUPTCY BRIEFING : J&J Unit Files Bankruptcy Over Talc Claims; Purdue Appeals to Be..
DJ
10/15PFIZER : Abrocitinib Receives Positive Opinion From European Regulator
MT
10/15Pfizer Gets Positive CHMP Opinion for Abrocitinib in Atopic Dermatitis
DJ
10/15JOHNSON & JOHNSON : Talc Claims Unit Files for Chapter 11 Bankruptcy; Company to Set Up $2..
MT
10/15CSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
MT
10/15ASTRAZENECA : France Sends AstraZeneca's COVID-19 Jabs to Nigeria Under COVAX
MT
10/15ROCHE : Joins PathAI to Develop AI-Based Image Analysis Workflow for Pathologists
MT
10/15US to Donate Over 17 Million Doses of Johnson & Johnson's COVID-19 Jab to African Union
MT
10/15PRESS RELEASE : Roche announces PathAI collaboration for artificial intelligence-based dig..
DJ
10/15Roche Announces PathAI Collaboration for Artificial Intelligence-Based Digital Patholog..
CI
10/14ELI LILLY AND : Releases Updated Data From Phase 3 Breast Cancer Trial
MT
10/14Eli Lilly and Company Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial ..
CI
10/14ROCHE : U.S. FDA advisers to review Merck's oral COVID-19 drug next month
RE
10/14ROCHE : AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation
MT
10/14NOVO NORDISK : Buy rating from Goldman Sachs
MD
10/14ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Buy rating
MD
10/14ROCHE : Scores Wins In Blood Cancer, Rare Nervous Disorder Therapeutic Areas
MT
10/14ROCHE HOLDINGS AG : Buy rating from Bernstein
MD
10/14ROCHE : Rare Central Nervous System Disease Therapy Reduces Relapses In Patients
MT
10/14ROCHE : Wins EU Nod For Shorter Gazyvaro Infusion Time in Follicular Lymphoma Patients
MT
10/14PRESS RELEASE : New four-year data show Roche's -2-
DJ
10/14PRESS RELEASE : New four-year data show Roche's ENSPRYNG significantly reduces debilitatin..
DJ
10/14Roche Holding Ag Announces New Longer-Term Efficacy and Safety Data for ENSPRYNG
CI
10/14PRESS RELEASE : Roche's Gazyvaro shorter 90-minute -2-
DJ
10/14PRESS RELEASE : Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for pe..
DJ
10/14Roche’s Gazyvaro Shorter 90-Minute Infusion Time Gets Approval in Europe for People wit..
CI
10/13Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine
RE
10/13Australia's CSL reiterates manufacturing commitment with AstraZeneca COVID-19 vaccine
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED
10/28/21